Is Vista Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Vista Pharmaceuticals Ltd (524711.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Vista Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vista Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Vista Pharmaceuticals Ltd?

Muslim investors may consider investing in Vista Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Vista Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Vista Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Vista Pharmaceuticals Ltd updated?

The Shariah compliance status of Vista Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Vista Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Vista Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Vista Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Vista Pharmaceuticals Ltd 524711.BO

₹7.75 ₹0.50 (6.90%) 1D

Last Updated: May 15, 12:00 AM·BSE

524711.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 27, 2026

Report Source: 2026 2nd Quarter Report

Vista Pharmaceuticals Ltd. Stock Analysis 524711.BO

India Health Care Nano Cap Report: Q2, 2026

Vista Pharmaceuticals Ltd. engages in the manufacture and market of pharmaceutical products. The firm offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The firm has its United States Food and Drug Administration (USFDA) approved manufacturing facility in India and its marketing and distribution center in United States. Its products include tablet dosage forms and capsule dosage forms. The firm's tablet dosage forms in United States market include sulfamethoxazole & trimethoprim (400/80 mg) and acetaminophen (500 mg) film coated. The firm's tablet dosage forms in Non-United States market include aspirin (300, 325 & 500 mg), atenolol (50 & 100 mg), cotrimoxazole (480 mg), captopril (25 & 50 mg) and frusemide (40 mg). Its capsule dosage forms in Non-United States market include indomethacin (25 mg), piroxicam (10 & 20 mg) and nifedipine (10 mg).

Key Statistics of Vista Pharmaceuticals Ltd (524711.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹7.25₹7.79

Today's Open

₹7.25

Volume

7854.00

P/E Ratio (TTM)

52 Week Range

₹5.71₹12.01

Market Cap

442.01M

Avg. Volume

8600.09

Dividend Yield

Financial Metrics & Statements of Vista Pharmaceuticals Ltd (524711.BO)

Community-Curated Collections with Vista Pharmaceuticals Ltd (524711.BO) ( With 524711.BO )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

Halal stock … India

By Abusaleha Syed

67 Followers

+76 more

FAQ's for Vista Pharmaceuticals Ltd (524711.BO)

According to Musaffa’s Shariah screening methodology, Vista Pharmaceuticals Ltd (524711.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.